<DOC>
	<DOCNO>NCT02437682</DOCNO>
	<brief_summary>The PASS test available valid tool evaluation persistent acid-related symptom patient receive PPI therapy . There lack validated Chines version PASS questionnaire GERD patient partial response proton pump inhibitor ( PPI ) . The English version PASS test translate traditional Chinese use forward-backward procedure , Chinese version PASS test validate psychometric property Hong Kong population . Eligible subject invite administer questionnaire evaluate psychometric property Chinese version PASS test .</brief_summary>
	<brief_title>Translation Validation PASS Test GERD Patients With Partial Response PPI Chinese Population : PASS-C</brief_title>
	<detailed_description>Gastro-esophageal reflux disease ( GERD ) common condition define symptom mucosal damage produce abnormal reflux gastric content esophagus . Symptoms highly specific GERD heartburn , regurgitation , , often occur meal . The prevalence GERD around 20 % weekly reflux symptom Western population , 9.3 % Chinese population . However , approximately 20-30 % patient GERD experience partial response heartburn regurgitation symptom PPI therapy . There lack validated Chines version PASS questionnaire GERD patient partial response PPI . Before treatment response assessment tool use clinically , various question reliability validity instrument need address . The aim study ( 1 ) translate PASS test English traditional Chinese , name PASS-C , ( 2 ) ass psychometric property PASS-C , clinical application . Linguistic translation PASS questionnaire English Chinese version follow forward-backward procedure . After finalization Chinese version PASS ( PASS-C ) , reliability PASS-C evaluate internal consistency use Cronbach 's alpha . The intraclass correlation coefficient calculate within 14 day two survey order evaluate reproducibility result constant condition . Pearson product moment correlation coefficient use evaluate whether PASS-C measure claim measure compare SF-12v2 , GERD QOL GREDSQ score . All eligible subject invite complete PASS-C twice within 14 day stable condition . In addition PASS-C , patient complete SF-12v2 , GERD-QOL , GERDQ GERDSQ questionnaire .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<criteria>Able give study inform consent Male female . Age 18 Have least 6 month history GERD symptom ( need consecutive ) chief complaint , e.g . acid regurgitation heartburn Subject take PPI standard dose least 8 week Subject persistent symptom PPI therapy GERDQ score â‰¥8 An upper gastrointestinal endoscopy require within past 1 year confirm absence mucosal break , peptic ulcer GI diseases e.g . gastric outlet obstruction Patients experience GERD symptom improvement PPI treatment Unstable clinically significant cardiovascular , respiratory , hepatic , renal , metabolic , psychiatric , clinical disorder , gastrointestinal esophageal disorder besides GERD . Clinically significant define disorder could compromise patient ' safety interfere evaluation study judge investigator . History current malignant disease Subject pregnant lactate Prior surgery upper GI tract ( open , endoscopic laparoscopic surgery esophagus , stomach duodenum ) Illiterate patient ( administer questionnaire ) Known hypersensitivity PPI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Gastro-esophageal Reflux Disease</keyword>
	<keyword>Proton pump inhibitor</keyword>
</DOC>